{
  "ticker": "IVVD",
  "company_name": "Invivyd, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05791318",
      "title": "A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "COVID-19",
      "start_date": "2023-03-28",
      "completion_date": "2024-05-08",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    },
    {
      "nct_id": "NCT04859517",
      "title": "Evaluation of ADG20 for the Prevention of COVID-19",
      "status": "TERMINATED",
      "phase": "PHASE2, PHASE3",
      "condition": "COVID-19",
      "start_date": "2021-04-27",
      "completion_date": "2022-11-04",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    },
    {
      "nct_id": "NCT06004128",
      "title": "Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "COVID-19",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    },
    {
      "nct_id": "NCT06523153",
      "title": "A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "COVID-19",
      "start_date": "2024-08-28",
      "completion_date": "2025-05",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    },
    {
      "nct_id": "NCT04805671",
      "title": "Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19",
      "status": "TERMINATED",
      "phase": "PHASE2, PHASE3",
      "condition": "COVID-19",
      "start_date": "2021-07-26",
      "completion_date": "2022-11-03",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    },
    {
      "nct_id": "NCT06039449",
      "title": "A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "COVID-19, SARS-CoV-2",
      "start_date": "2023-09-08",
      "completion_date": "2024-11-19",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    },
    {
      "nct_id": "NCT07298434",
      "title": "Study of VYD2311 for the Prevention of COVID-19",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "COVID-19",
      "start_date": "2026-01-08",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "Invivyd, Inc."
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1": 2,
      "PHASE2, PHASE3": 2,
      "": 1,
      "PHASE3": 2
    },
    "by_status": {
      "COMPLETED": 2,
      "TERMINATED": 2,
      "NO_LONGER_AVAILABLE": 1,
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 2,
    "conditions": [
      "COVID-19",
      "COVID-19, SARS-CoV-2"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:15.931647",
    "search_query": "Invivyd, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Invivyd,+Inc."
  }
}